195 related articles for article (PubMed ID: 24922062)
21. Characterization of two novel retinoic acid-resistant cell lines derived from HL-60 cells following long-term culture with all-trans-retinoic acid.
Mori J; Suzuki S; Hara M; Kaneko A; Yamashita K; Kumagai M; Sakuma T; Kakizawa T; Yamazaki M; Takeda T; Miyamoto T; Ichikawa K; Hashizume K
Jpn J Cancer Res; 1999 Jun; 90(6):660-8. PubMed ID: 10429659
[TBL] [Abstract][Full Text] [Related]
22. Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells.
Kizaki M; Nakajima H; Mori S; Koike T; Morikawa M; Ohta M; Saito M; Koeffler HP; Ikeda Y
Blood; 1994 Jun; 83(11):3289-97. PubMed ID: 8193364
[TBL] [Abstract][Full Text] [Related]
23. Combined vitamin D3/retinoic acid induction of human promyelocytic cell lines: enhanced phagocytic cell maturation and hybrid granulomonocytic phenotype.
Masciulli R; Testa U; Barberi T; Samoggia P; Tritarelli E; Pustorino R; Mastroberardino G; Camagna A; Peschle C
Cell Growth Differ; 1995 May; 6(5):493-503. PubMed ID: 7647032
[TBL] [Abstract][Full Text] [Related]
24. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.
Asou H; Koike M; Elstner E; Cambell M; Le J; Uskokovic MR; Kamada N; Koeffler HP
Blood; 1998 Oct; 92(7):2441-9. PubMed ID: 9746784
[TBL] [Abstract][Full Text] [Related]
25. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of activity of 1alpha, 25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha-tocopherol ester of all-trans retinoic acid.
Makishima M; Kanatani Y; Yamamoto-Yamaguchi Y; Honma Y
Blood; 1996 Apr; 87(8):3384-94. PubMed ID: 8605356
[TBL] [Abstract][Full Text] [Related]
27. Retinoic acid induces expression of SLP-76: expression with c-FMS enhances ERK activation and retinoic acid-induced differentiation/G0 arrest of HL-60 cells.
Yen A; Varvayanis S; Smith JL; Lamkin TJ
Eur J Cell Biol; 2006 Feb; 85(2):117-32. PubMed ID: 16439309
[TBL] [Abstract][Full Text] [Related]
28. RRD-251 enhances all-trans retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells.
Wallace AS; Supnick HT; Bunaciu RP; Yen A
Oncotarget; 2016 Jul; 7(29):46401-46418. PubMed ID: 27331409
[TBL] [Abstract][Full Text] [Related]
29. c-Cbl tyrosine kinase-binding domain mutant G306E abolishes the interaction of c-Cbl with CD38 and fails to promote retinoic acid-induced cell differentiation and G0 arrest.
Shen M; Yen A
J Biol Chem; 2009 Sep; 284(38):25664-77. PubMed ID: 19635790
[TBL] [Abstract][Full Text] [Related]
30. RB phosphorylation in sodium butyrate-resistant HL-60 cells: cross-resistance to retinoic acid but not vitamin D3.
Yen A; Varvayanis S
J Cell Physiol; 1995 Jun; 163(3):502-9. PubMed ID: 7775593
[TBL] [Abstract][Full Text] [Related]
31. Alterations of differentiation, clonal proliferation, cell cycle progression and bcl-2 expression in RAR alpha-altered sublines of HL-60.
Grillier I; Umiel T; Elstner E; Collins SJ; Koeffler HP
Leukemia; 1997 Mar; 11(3):393-400. PubMed ID: 9067579
[TBL] [Abstract][Full Text] [Related]
32. Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells.
Witcher M; Shiu HY; Guo Q; Miller WH
Blood; 2004 Nov; 104(10):3335-42. PubMed ID: 15256426
[TBL] [Abstract][Full Text] [Related]
33. Evidence of off-target effects of bosutinib that promote retinoic acid-induced differentiation of non-APL AML cells.
Kazim N; Yen A
Cell Cycle; 2021 Dec; 20(24):2638-2651. PubMed ID: 34836491
[TBL] [Abstract][Full Text] [Related]
34. Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells.
MacDonald RJ; Bunaciu RP; Ip V; Dai D; Tran D; Varner JD; Yen A
Leuk Lymphoma; 2018 Dec; 59(12):2941-2951. PubMed ID: 29569971
[TBL] [Abstract][Full Text] [Related]
35. Control of HL-60 cell differentiation lineage specificity, a late event occurring after precommitment.
Yen A; Forbes M; DeGala G; Fishbaugh J
Cancer Res; 1987 Jan; 47(1):129-34. PubMed ID: 3466687
[TBL] [Abstract][Full Text] [Related]
36. Increased sensitivity to a vitamin D3 analog in HL-60 myeloid leukemic cells resistant to all-trans retinoic acid.
Doré BT; Uskokovic MR; Momparler RL
Leukemia; 1994 Dec; 8(12):2179-82. PubMed ID: 7528858
[TBL] [Abstract][Full Text] [Related]
37. 3-Deazauridine triggers dose-dependent apoptosis in myeloid leukemia cells and enhances retinoic acid-induced granulocytic differentiation of HL-60 cells.
Savickiene J; Gineitis A
Int J Biochem Cell Biol; 2003 Oct; 35(10):1482-94. PubMed ID: 12818243
[TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features.
Kizaki M; Matsushita H; Takayama N; Muto A; Ueno H; Awaya N; Kawai Y; Asou H; Kamada N; Ikeda Y
Blood; 1996 Sep; 88(5):1824-33. PubMed ID: 8781440
[TBL] [Abstract][Full Text] [Related]
39. Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation.
Brugnoli F; Lambertini E; Varin-Blank N; Piva R; Marchisio M; Grassilli S; Miscia S; Capitani S; Bertagnolo V
Exp Cell Res; 2010 Jan; 316(1):38-47. PubMed ID: 19747912
[TBL] [Abstract][Full Text] [Related]
40. Activation of the aryl hydrocarbon receptor AhR Promotes retinoic acid-induced differentiation of myeloblastic leukemia cells by restricting expression of the stem cell transcription factor Oct4.
Bunaciu RP; Yen A
Cancer Res; 2011 Mar; 71(6):2371-80. PubMed ID: 21262915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
